Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ

1.66

-0.03(-1.78%)

Updated at April 28 04:00PM

Currency In USD

Valuation

Market Cap417.51M
Enterprise Value445.42M
P/E Ratio-12.17
PEG Ratio-0.06
Price/Sales Ratio14.34
Price/Book Ratio5.69
Enterprise/Revenue14.9
Enterprise/EBITDA-17.39

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-1.01
Operating Margin-0.98

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.42

Income Statement

Revenue49.8M
Revenue/Share0.14
Gross Profit49.53M
EBITDA-48.29M
Net Income-50.34M
Diluted EPS-0.14

Balance Sheet

Total Cash96.23M
Total Cash/Share0.26
Total Debt62.24M
Total Debt/Equity0.58
Current Ratio4.88
Book Value Per Share0.3

Price History

52-Week Change144.19
52-Week High1.95
52-Week Low0.51
Moving Average 50 Days1.63
Moving Average 200 Days1.37

Statistics

Average Volume2.71M
Shares Outstanding423.68M
% Held by Institutions71.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:7
Last Split DateMay 21, 2015